Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit

5AM Venture Management sold 170,000 shares of Praxis Precision Medicines in the fourth quarter. The quarter-end position value decreased by $9.01 million as a result of the move, which marked a full exit from Praxis.